Lang, M., Hackert, T., & Anamaterou, C. (2021). Long-term effect of everolimus in recurrent thymic neuroendocrine neoplasia. Clinical endocrinology, 95(5), . https://doi.org/10.1111/cen.14572
Chicago Style (17th ed.) CitationLang, Matthias, Thilo Hackert, and Chrysanthi Anamaterou. "Long-term Effect of Everolimus in Recurrent Thymic Neuroendocrine Neoplasia." Clinical Endocrinology 95, no. 5 (2021). https://doi.org/10.1111/cen.14572.
MLA (9th ed.) CitationLang, Matthias, et al. "Long-term Effect of Everolimus in Recurrent Thymic Neuroendocrine Neoplasia." Clinical Endocrinology, vol. 95, no. 5, 2021, https://doi.org/10.1111/cen.14572.
Warning: These citations may not always be 100% accurate.